BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 29
• 30

• Emory University Names Pilgrim Software as Clinical Trial Auditing Solution Provider

  November 11, 2010

   · 

  3 min read
• BioCapital

  HHS Announces New Tobacco Strategy and Proposed New Warnings and Graphics for Cigarette Packs and Advertisements

  November 11, 2010

   · 

  4 min read
• Pharm Country

  Catalent Pharma Solutions Expands Its Controlled Release Development Capabilities

  November 11, 2010

   · 

  2 min read
• Merck & Co., Inc. Climbs on the Emerging Markets Bandwagon

  November 11, 2010

   · 

  1 min read
• Business

  Frontage Laboratories Partners With the Greater New Orleans Foundation to Support Oil Spill Relief Fund at AAPS 2010

  November 11, 2010

   · 

  2 min read
• Lone Star Bio

  Digisonics OB/GYN Customer Expands to Vascular Department

  November 11, 2010

   · 

  1 min read
• Deals

  Ikaria Inc. Withdraws IPO, Leaving Arch, Hutch in the Lurch

  November 11, 2010

   · 

  1 min read
• Drug Development

  Novartis AG Stops Lung Cancer Drug Trial of ASA404, Developed in Partnership with Antisoma PLC, Books $120 Million Charge

  November 11, 2010

   · 

  2 min read
• Drug Development

  SuperGen, Inc. Discontinues Clinical Development of SGI-1776, a Phase I PIM Inhibitor

  November 11, 2010

   · 

  2 min read
• FDA

  FDA Approves Theratechnologies Inc.'s EGRIFTA(TM) (Tesamorelin for Injection): First and Only Treatment for the Reduction of Excess Abdominal Fat in HIV-infected Patients with Lipodystrophy

  November 11, 2010

   · 

  17 min read